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1. Introduction 
Dihydrofolate reductase (5,6,7,%tetrahydrofolate: 
NADP’-oxidoreductase, EC 1.5.1.3) appears to be the 
major intracellular receptor for the action of 4-amino 
analogs of folic acid, such as amethopterin (4-amino- 
1 O-methyl-4-deoxyfolate). Such analogs have been 
employed extensively in the chemotherapeutic treat- 
ment of certain leukemias, lymphomas and other 
clinical disorders [ 1,2]. In addition, a differential 
sensitivity to certain drugs, such as trimethoprim, by 
mammalian and bacterial reductases have lead to the 
development of a class of compounds with potent 
antibacterial activity [3]. The underlying differential 
inhibitory effects of certain classical drugs as trimeth- 
oprim must reside in differences in the three-dimen- 
sional architecture of the active centers of bacterial 
versus mammalian dihydrofolate reductases. Thus, a 
knowledge of the complete primary and tertiary 
structures of dihydrofolate reductases from both 
bacterial and mammalian sources in the presence and 
absence of inhibitors, coenzymes, and substrates 
should aid in our understanding of these differential 
inhibitory effects. 
In the present communication the primary structure 
of dihydrofolate reductase from an amethopterin-resis- 
tant strain of Lactobacillus casei of 162 residues is 
reported and compared with two bacterial reductases 
whose sequences have been previously described. 
Adress correspondence to: J. H. Freisheim 
North-Holland Publishing Company - Amsterdam 
2. Experimental 
Dihydrofolate reductase was purified from an 
amethopterin-resistant strain of L. casei by a modi- 
fication [4] of the procedure of Gundersen et al. [5] . 
Automated sequence analysis was performed with the 
Beckman Sequencer (Model 890C) on the intact 
protein and on most of the derived peptides as 
previously described [6]. Digestion of the protein with 
CNBr at methionine residues and subsequent purifica- 
tion of the resulting peptides were done as described 
by Freisheim et al. [6] . Digestion of peptide fragments 
with ‘TPCK-Trypsin’ was performed according to 
conventional procedures. The digest was fractionated 
on Sephadex G-50 (superfine). Some of the smaller 
tryptic peptides were further purified either by gel 
filtration on Sephadex G-25 (fine), on Bio-Gel P-6 or 
by ion-exchange chromatography. Digestion of CNBr-II 
with S. aureus protease was done according to Houmard 
and Drapeau [7]. Separation of the resulting peptides 
was achieved on Sephadex G-50. Some of the lower 
molecular weight S. aureus protease peptides were 
purified by gel filtration on Bio-Gel P-6 or by 
electrophoresis (pH 6.5) followed by paper chromato- 
graphy in the solvent system: butanol/glacial acetic 
acid/pyridine/water (15:3: 10: 12). Cleavage of peptides 
with the Myxobacter protease was performed as 
described by Wingard et al. [8] . Digestions employing 
carboxypeptidase C were performed according to 
Tschesche and Kupfer [9] and those employing 
carboxypeptidases A and B were performed essentially 
as determined by Morris et al. [ 121 employing mass 
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were performed using a Durrum Model D-500 amino 
acid analyzer after acid hydrolysis according to the 
general procedures of Moore and Stein [ Ill. 
3. Results and discussion 
The alignment of the three CNBr fragments has 
been described [6]. Automated sequencer analyses 
were performed on the three CNBr fragments as well 
as on tryptic, Myxobacter protease Al-l and S. aureus 
protease peptides to obtain overlap data. The sequence 
of the L. casei dihydrofolate reductase is shown in 
fig.1. 
These results are in agreement with the sequence of 
most of the elastase peptides from an L. casei reductase 
as determined by Morris et al. [ 121 employing mass 
spectrometry. 
The amino-acid sequence of dihydrofolate reductase 
from the amethopterin-resistant strain of L. casei 
described is based on present data and on those 
reported previously from this laboratory [6]. The 
molecular weight calculated from the sequence is 
approx. 18 300. 
Comparison of the amino-acid sequence of the 
L. casei reductase with those obtained for enzymes 
from S. faecium [ 131 and Escherichia coli [ 141 are 
shown in fig. 1. Optimal alignment of the three 
sequences required the assumption that the L. casei 
reductase is lacking the first residue which is Met in 
the other two enzymes. The L. casei reductase sequence 
shows a 29% identity with that of the E. coli enzyme 
and a 34% identity with that of the S. faecium enzyme 
with the alignments given in fig. 1. A similar comparison 
of the S. faecium and E coli reductases gives 32% 
identical residues. If minimum single-base changes are 
also included, the homology comparisons vary between 
64% and 73% as indicated in table 1. 
Thr-Ala-Phe-Leu Trp-A a-G n As"-Arg Asp-G1 -Le"-I e- y-Lys-Asp-GlyfHis Leu-Pro-Trp His Leu-Pro 
'~~~~ls-V:4AsP~=~-"sl,*~e-~~~~et-Gl GlylLe"+~[Ar~~~ Met-Ile-Ser-Leu-Ile- n-Asn-Ala- et Pro-Trp As" Leu-Pro 
Met-Phe-Ile-Ser-Met Tr -Ala-G n Asp-Lys-AsntGly-Leu-Ile-Gly-Lys-Asp- 
-Asp~His-T~~~~ls-Gln~l-Gly~~~~Vsl~~~~~~P~~- 
-Ala Asp-Leu Ala-Trp Phe L s-Arg-As" Thr Leu-Asp Lys Pro-Val-I e-net Gly-Arg His ThrwGlu-Ser Ile- 
-Asn Asp Met-Arg-Phe Phe-Arg Glu-His Thr Met-Asp Lys- e LeumMet Gly-Arg Lys Thr-Tyr-Glu Gly-Met- 
105 110 115 
-Ala-Gln-Ile-Phe-Thr-Ala-Phe-Lys-Asp-Asp-Val-Asp-Thr-Le" 
-Arg-Val-Tyr-Glu-Gln-Phe-Le"-Pro-Lys-Ala-Gl"-Lys-Le"-Tyr 
-Arg-Ile-Phe-Gln-Ala-Le"-Leu-Pro-Gl"-Thr-Lys-Ile-Ile-Trp-A~g- 
120 
Arg-Leu-Ala-Gly-Ser 
Leu-Ile-Asp-Ala-Glu 
130 135 140 145 150 
Asp-T r 
t 
Lys-Met-Ile-Pro-Leu-As"-Trp Asp- sp- Ser Ser Arg-Thr-Val-Glu-Asp-Thr-Asn-Pro- 
Asp-Thr His-Phe-Pro-Asp-Tyr-Glu-Pro AS 
As -Thr 
#p-:5psThr-lysn p 
Tr -Glu-Ser Val Phe Ser Glu-Phe-His-Asp-Ala-Asp-Ala-Gln- 
phe-Ile-Gly-Glu-Ile-Asp-Phe-Thr-Ser P e Glu-Leu Val Glu-G u-His-Glu-Gly-Ile-Val-Asn-Gln-Glu- 
-Asn-Gln-Tyr-Pro-His-Arg- 
Fig.1. Comparison of the amino acid sequences of dihydrofolate reductase from L. casei (upper sequence), E. coli (middle 
sequence [ 14]), and X faecium (lower sequence [ 13]), Positions at which the L. casei enzyme is identical to one or more 
of the other proteins are enclosed. Position numbers are based on the E: coli sequence. Gaps are introduced to achieve 
maximum homology. 
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Table 1 
Comparison of the amino acid sequences of dihydrofolate reductases from L. casei, E. coli 
and S. faeciuma 
Sequences compared Mm. Base Changes, 7ob Mean Base Change per/COdon 
0 0+1 
I_. casei res. l-68 54 91 0.55 
to 
S. faecium total sequence 34 73 0.94 
L. casei res. l-68 39 79 0.82 
to 
E. coli total sequence 29 64 1.08 
E. coli res. l-68 37 75 0.88 
to 
S. .faecium total sequence 32 72 0.98 
- 
aThe comparisons are based on the sequence alignments indicated in fig.1 
bThe percentages are based on the minimum number of base changes necessary to change the 
amino acid residue in one sequence to that found at the same position in the sequence being 
compared 
In agreement with the conclusions of Gleisner et al. 
[ 131 who compared the S. faecium and E. coli MB 
1428 reductase sequences, it is evident that the amino- 
terminal regions of the three proteins are highly con- 
served. The first 68 residues of these amino-terminal 
regions constitute the longest set of clusters of identical 
residues (cf. iig.l). It is clear in comparing reductase 
sequences from L. casei and S. faecium, both folate- 
requiring organisms, that these two exhibit the greatest 
degree of homology in this region as shown in table 1. 
These two enzymes show a 54% identity in the first 
68 residues with a mean base change per codon of 
0.55 as compared with 0.82 and 0.88, respectively, 
when the L. casei/E. coli and E. coli/S. faecium 
reductase sequences are similarly examined. The high 
degree of conservation of amino acid residues in the 
amino-terminal portion of the dihydrofolate reductases 
examined suggests a functional involvement for certain 
residues in this region of the molecule. 
Previous chemical modification studies [6] have 
implicated Trp-22 in the function of L. casei 
dihydrofolate reductase. The position of this tryptophan 
is conserved in enzymes from at least five different 
species [6]. The common sequence among bacterial 
reductases is: Leu/Met-Pro-Trpzz-X-Leu-Pro-X- 
Asp-Leu/Met ([6], cf. fig.1). The proline residue at 
positions 21 and 25 may serve to position Trp-22 
into the appropriate configuration for optimum binding 
interactions. In addition, one lysine [ 151 and at least 
two arginine residues [ 161 have been implicated in either 
folate or NADPH binding, although these residues have 
not, as yet, been placed in the L. casei enzyme sequence. 
Recently Matthews et al. [17] have described con- 
tact residues involved in the binding of Methotrexate 
(MTX) to the E. coli reductase by means of X-ray 
crystallographic analyses. Based in part on sequence 
alignments suggested by this laboratory (cf. fig.1) 
certain residues have been implicated in the binding 
of14TX to dihydrofolate reductase [ 171. Based on the 
alignments indicated in fig. 1, it appears that Arg-58 and 
either Arg- or Lys-32 are involved in the binding of 
the cr- and fl-carboxyl groups, respectively, of the L-Glu 
moiety of the MTX molecule. Residue Asp*,, which is 
identical in the three bacterial enzymes (cf. fig.1) may 
play an important role in binding of several atoms of 
the MTX molecule [ 171. In addition, Arg-44, which is 
identical in all three bacterial species, may be involved 
in the binding of the 2’-phosphate in NADPH, as 
suggested by Matthews et al. [ 171. 
The molecular details of the interaction of L. casei 
dihydrofolate reductase with NADPH in the presence 
and absence of MTX remain to be elucidated, but such 
studies are in progress (D. A. Matthews and J. Kraut, 
personal communication). 
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